Please Share:: 
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Result Previews – 3QFY2011
Glaxosmithkline Pharma
Glaxosmithkline Pharma (Glaxo) is scheduled to announce its 4QCY2010E results. We
expect Glaxo to post net sales at `511cr, an increase of 15%. OPM is expected to contract by
118bp yoy to 30%. Net profit is expected to increase by 15.3% yoy to `119.7cr. We currently
have a Neutral recommendation on the stock.
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Result Previews – 3QFY2011
Glaxosmithkline Pharma
Glaxosmithkline Pharma (Glaxo) is scheduled to announce its 4QCY2010E results. We
expect Glaxo to post net sales at `511cr, an increase of 15%. OPM is expected to contract by
118bp yoy to 30%. Net profit is expected to increase by 15.3% yoy to `119.7cr. We currently
have a Neutral recommendation on the stock.
No comments:
Post a Comment